Washington Post |
A “breathholding time” for Alzheimer's research as trials focus on seeking a cure
Washington Post At the annual Alzheimer's Association International Conference this week, attendees eagerly anticipated the result of a 15-month trial of a new drug to combat the disorder. If successful, it could potentially have been one of the first effective ... Some doctors won't diagnose Alzheimer's Alzheimer's disease more likely in patients with cerebral vascular disease Eye tests could help spot dementia, research suggests |
A “breathholding time” for Alzheimer's research as trials focus on seeking a cure - Washington Post
Read More
0 Response to "A “breathholding time” for Alzheimer's research as trials focus on seeking a cure - Washington Post"
Post a Comment